BioMaxima S.A. (WSE:BMX)
Poland flag Poland · Delayed Price · Currency is PLN
14.00
-0.60 (-4.11%)
Jun 6, 2025, 4:42 PM CET

BioMaxima Revenue

BioMaxima had revenue of 15.52M PLN in the quarter ending March 31, 2025, with 34.59% growth. This brings the company's revenue in the last twelve months to 56.64M, up 19.41% year-over-year. In the year 2024, BioMaxima had annual revenue of 52.85M with 12.96% growth.

Revenue (ttm)
56.64M
Revenue Growth
+19.41%
P/S Ratio
1.03
Revenue / Employee
449.56K
Employees
126
Market Cap
58.28M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202452.85M6.07M12.96%
Dec 31, 202346.79M-97.08M-67.48%
Dec 31, 2022143.87M64.78M81.91%
Dec 31, 202179.09M17.81M29.06%
Dec 31, 202061.28M30.67M100.19%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NEUCA 12.82B
Synektik Spólka Akcyjna 556.63M
Voxel 556.98M
Celon Pharma 215.11M
Ryvu Therapeutics 97.57M
Centrum Medyczne ENEL-MED 735.59M
Selvita 359.79M
EMC Instytut Medyczny 836.81M
Revenue Rankings